Longevity Health Holdings Overview
Longevity Health Holdings (XAGE) has a ROE of 78.49%, above the sector sector average of -5.68%.
Get informed when a big investor buys or sells
+ Follow78.49%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Longevity Health Holdings (XAGE) currently reports a ROE of 78.49%. That is above the sector sector average of -5.68%. Use the charts on this page to explore Longevity Health Holdings's ROE history and peer comparisons.
Longevity Health Holdings's ROE of 78.49% is higher than the its sector sector average of -5.68%. That is roughly 1481.2% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Longevity Health Holdings's current 78.49% should be judged against industry norms (sector average: -5.68%) and against XAGE's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of 78.49%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is -5.68%. From there, open related valuation or income-statement pages for Longevity Health Holdings, and consider following XAGE for alerts when major investors trade the stock.
